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Iron acquisition by siderophores is crucial for survival
and virulence of many microorganisms. Here, we
investigated the binding of the exogenous sidero-
phore ferric enterobactin and the synthetic sidero-
phore mimic ferric mecam by the triscatecholate
binding protein FeuA from Bacillus subtilis at the
atomic level. The structural complexes provide
molecular insights into the capture mechanism of
FeuA for exogenous and synthetic siderophores.
The protein-ligand complexes show an exclusive ac-
ceptance ofL-stereoconfigured substrates. Ligand-
induced cross-bridging of the complexes was not
observed, revealing a different thermodynamic be-
havior especially of the ferric mecam substrate,
which was previously shown to dimerize with the en-
terobactin binding protein CeuE. The nearly identical
overall domain movement of FeuA upon binding of
ferric enterobactin or ferric mecam compared with
endogenously derived ferric bacillibactin implies
the importance of the conserved domain rearrange-
ment for recognition by the transmembrane per-
mease FeuBC, for which the conserved FeuA resi-
dues E90 and E221 were proved to be essential.
INTRODUCTION
Iron acquisition is a major challenge for microbial species,
regarding its very low bioavailability for both pathogenic and
nonpathogenic strains (free iron[III] concentration of 1024 M
in serum; Carrano and Raymond, 1979) and 109 to 1018 M in
the environment at neutral pH (Chipperfield and Ratledge,
2000; Raymond and Carrano, 1979). Among several evolved
strategies, one of the most prominent ways to overcome iron
deprivation is the secretion of siderophores and their subse-
quent reimport in complex with iron(III) (Miethke and Marahiel,
2007). These low-molecular-weight organic compounds
possess extraordinary high affinities toward ferric iron (up to
1048 M1 for bacillibactin (BB) (Dertz et al., 2006) and 1049 M1
for enterobactin (Ent) (Loomis and Raymond, 1991)).Chemistry & Biology 18,Siderophores secreted by pathogenic bacteria are critical for
their survival in mammalian hosts whose iron homeostasis is
strictly regulated; therefore siderophores often represent viru-
lence factors. The innate immune defense protein siderocalin
(also referred to as lipocalin 2 or neutrophile gelatinase associ-
ated lipocalin (NGAL)) is involved in the sequestration of iron
bound by catecholate siderophores (Goetz et al., 2002), cate-
cholamines (Miethke and Skerra, 2010) or even catechole (Bao
et al., 2010), thereby reducing the pool of available iron for path-
ogens. This defense mechanism is directed against the most
prominent siderophores: enterobactin from Gram-negative
bacteria (Goetz et al., 2002), bacillibactin from Gram-positive
bacteria (Abergel et al., 2006), and carboxymycobactins from
mycobacteria (Holmes et al., 2005).
Bacteria also use low-affinity siderophore precursors, such as
2,3-dihydroxybenzoate (2,3-DHB) byBacillus subtilis (Peters and
Warren, 1968) and Escherichia coli (Hancock et al., 1977), and
3,4-dihydroxybenzoate (3,4-DHB) by Bacillus anthracis (Garner
et al., 2004) to complex ferric ions. However, an additional
common survival strategy of pathogenic and nonpathogenic
bacteria is the capture of siderophores which are not produced
by themselves, so-called exogenous, or xeno-siderophores.
The Gram-positive model organism B. subtilis utilizes bacilli-
bactin as endogenous siderophore (May et al., 2001; Miethke
et al., 2006) and can further import the exogenous siderophores
enterobactin, petrobactin, or hydroxamate-type siderophores
such as ferrichrome or schizokinen (Ollinger et al., 2006;
Zawadzka et al., 2009).
Siderophore import in bacteria is accomplished by complex
transport machineries. Gram-negative bacteria possess highly
specialized b-barrel-shaped outer membrane receptors, which
bind a specific siderophore, such as FepA for ferric enterobactin
or FhuA for ferric hydroxamates (Braun and Braun, 2002; Chak-
raborty et al., 2007). Further transport from the periplasm to the
cytoplasm is carried out by ATP-binding cassette-type (ABC)
transporters, which comprise two transmembrane permease
components, two nucleotide-binding domains, and a periplas-
mic binding protein. In Gram-positive bacteria, the periplasmic
binding proteins are substituted by so-called substrate binding
proteins (SBPs), which are tethered to the cytoplasmic
membrane by lipid anchors. SBPs from both Gram-negative
and Gram-positive bacteria are generally more promiscuous
than the outer membrane receptors of Gram-negative bacteria
and may transport a whole class of siderophores, rather than
one specific compound (Krewulak and Vogel, 2008).907–919, July 29, 2011 ª2011 Elsevier Ltd All rights reserved 907
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Figure 1. Structures of Prominent Triscatecholate Siderophores
Shown are the triscatecholate siderophores bacillibactin, enterobactin, and vibriobactin, the triscatecholate siderophore mimeticum mecam, and the precursor
2,3-dihydroxybenzoic acid. The iron coordinating groups are shown in red.
Chemistry & Biology
Uptake of Fe-Enterobactin and Fe-mecam by FeuAThe FeuABC-YusV2 transporter of B. subtilis was shown to
import ferric complexes of both bacillibactin and enterobactin
(Miethke et al., 2006; Ollinger et al., 2006). Recently, we solved
the structure of the FeuA$[FeIII(BB)]3 complex at 1.70 A˚ resolu-
tion (Peuckert et al., 2009), which revealed a basic triad
composed of K84, K105, and R180 to be mainly responsible
for binding of the ligand. The C-terminal domain of FeuA shifts
about 20 relative to the N-terminal domain when the ligand is
bound, which is the largest known domain movement for
a member of the ‘‘helical-backbone’’ metal-receptor super-
family, the so-called class III. Ferric bacillibactin was found in
its L-stereoconfiguration in the holo-FeuA structure. Further,
the ferric complexes of enterobactin and the triscatecho-
late siderophore mimic mecam (H6-mecam = 1,3,5-N,N
0,N00-
tris[2,3-dihydroxybenzoyl]triaminomethylbenzene) showed a L-
stereoconfiguration when bound by FeuA in solution (Peuckert
et al., 2009). In contrast, free-solvated ferric enterobactin was
shown to adopt a D-configuration (Karpishin et al., 1993).
To elucidate the structure-functional relationship of xeno-
siderophore binding, we investigated the structural basis for
the substrate promiscuity of FeuA, in regard to the exogenous
siderophore enterobactin, and its nonhydrolyzable synthetic
analog, mecam. Cocrystal structures of the FeuA$[FeIII(Ent)]3
and FeuA$[FeIII(mecam)]3 complexes provide structural in-
sights into the binding modes of structurally related triscate-
cholate substrates. Binding of further distantly related sidero-
phores including vibriobactin (VB) and 2,3-DHB (Figure 1)
was additionally studied by spectroscopic measurements in
solution.908 Chemistry & Biology 18, 907–919, July 29, 2011 ª2011 Elsevier LRESULTS
Overall Structures
The complexes of FeuA with [FeIII(Ent)]3 and [FeIII(mecam)]3
both crystallized in space groupP21, as did the FeuA$[Fe
III(BB)]3
complex (PDB code: 2WHY) reported previously (Peuckert
et al., 2009). The crystals were obtained under similar conditions;
the cell dimensions are similar to those of the known complex
and contain also one monomer per asymmetric unit. Both
structures were solved by molecular replacement using the
structure of the FeuA$[FeIII(BB)]3 complex as a model and
X-ray data to a resolution of 1.90 A˚ for FeuA$[FeIII(Ent)]3 and of
2.15 A˚ for FeuA$[FeIII(mecam)]3. Detailed data collection and
refinement statistics are given in Table 1; the overall structures
of both complexes are shown in Figures 2A and 2B.
Residues 1–18 in the N-terminal domain of the mature protein
and 300–305 in the C-terminal domain of FeuA$[FeIII(Ent)]3 and
1–17 and 301–305 of FeuA$[FeIII(mecam)]3 could not be
modeled, as was already the case for the FeuA$[FeIII(BB)]3
structure. This is most likely due to disorder in the N- and
C-terminal regions, which was predicted using the DISOPRED2
server (Ward et al., 2004).
Both complexes are remarkably similar to the FeuA$
[FeIII(BB)]3 complex. The domain tilting upon ligand binding is
20.8 for the [FeIII(Ent)]3 and 20.4 for the [FeIII(mecam)]3
complex, which is comparable to the 20.2 shift observed for
the FeuA$[FeIII(BB)]3 complex compared with apo-FeuA (PDB
code: 2WI8). When overlaying the N-terminal domains, apo-
and holo-FeuA can be clearly discriminated by the distancetd All rights reserved
Table 1. Crystallographic Data Collection and Refinement
Statistics
Data Processing FeuA$[FeIII(Ent)]3 FeuA$[FeIII(mecam)]3
PDB code 2XUZ 2XV1
Beamline ID14-2, ESRF ID14-2, ESRF
Wavelength (A˚) 0.933 0.933
Detector ADSC Q4 CCD ADSC Q4 CCD
Space group P21 P21
a, b, c (A˚) 36.44, 63.56, 56.52;
b = 100.65
39.96, 63.44, 56.21;
b = 110.27
Resolution (A˚) 41.83–1.90 40.55–2.15
Total reflectionsa 61,441 (8791) 41,311 (6091)
Unique reflectionsa 19,907 (2852) 13,962 (2074)
Completenessa 99.1 (97.7) 96.9 (98.3)
hIi / shIia 14.8 (2.5) 18.4 (2.2)
Rmerge
a,b 0.058 (0.493) 0.046 (0.595)
Mosaicity () 0.520 0.251
Wilson B factor (A˚2) 21.4 39.1
Refinement
Rwork, Rfree
c,d 18.47, 24.32 17.81, 23.66
Used reflections 18,136 12,740
Mean B factor (A˚2) 22.4 38.3
No. of atoms 2430 2314
Rmsd from ideal
Bond lengths (A˚) 0.0091 0.0084
Bond angles () 1.213 1.142
a Values in parentheses correspond to the highest resolution shell.
b Rmerge = Shkl Si (Ii(hkl)  < I(hkl) >) / Shkl Si Ii(hkl).
c Rwork = S (Fobs-Fcalc) / S (Fobs).
d Rfree crystallographic R factor based on 5.0% (FeuA$[Fe
III(Ent)]3) and
7.2% (FeuA$[FeIII(mecam)]3), respectively, of the data withheld from
the refinement for cross-validation.
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Uptake of Fe-Enterobactin and Fe-mecam by FeuAbetween the two conserved glutamate residues E90 and E221,
which are assumed to form salt bridges with conserved arginine
residues of the transmembrane permease components FeuB
(R59) and FeuC (R53), thereby triggering the substrate transloca-
tion through the cytoplasmic membrane. This attribution is
based on similar observations for the vitamin B12 (Btu) (Borths
et al., 2002; Hvorup et al., 2007) and the ferric citrate (Fec) (Braun
and Herrmann, 2007) uptake systems of E. coli and the ferric
hydroxamate uptake system (Fhu) of Staphylococcous aureus
(Sebulsky et al., 2003). The distance between E90 and E221 is
48.5 A˚ for apo-FeuA and 44.4 A˚ for holo-FeuA, with an angle of
13 and a distance of 11.3 A˚ between apo- and holo-E221,
calculated for the Ca atoms (Figure 2C).
The superposition of the complexes with FeuA$[FeIII(BB)]3
reveals root mean square deviations of 0.38 A˚ for in total 278
Ca positions of FeuA$[Fe
III(Ent)]3 and 0.26 A˚ for in total 282 Ca
positions of FeuA$[FeIII(mecam)]3 (Figure 2D). Diverse structural
elements were located mainly at the flexible N and C termini,
most likely caused by differences in crystal packing, expressed
in slightly different cell parameters.
As expected, both ligands are stabilizing the overall protein
fold which is displayed by significantly increased melting temp-
eratures, which were monitored by circular dichroism spectros-Chemistry & Biology 18,copy. The FeuA$[FeIII(Ent)]3 and FeuA$[FeIII(mecam)]3 com-
plexes showed melting temperatures that are between 8C
and 10C higher than that of apo-FeuA. These results are in
the same range observed for FeuA$[FeIII(BB)]3. In contrast,
the ferric complexes of 2,3-DHB, FeIII(2,3-DHB)3, and of vibrio-
bactin, [FeIII(VB)]3, did not enhance the overall folding stability
of FeuA (see Figure S1 available online).
Siderophore Binding
The FeuA$[FeIII(BB)]3 complex revealed a basic triad, made up
of K84 and K105 provided by the N-terminal domain and R180
from the C-terminal domain. Q181 and Q215 were the only other
binding pocket forming residues, which showed additional direct
interactions with the ligand by hydrogen bonding. However, the
basic triad was shown to be mainly responsible for binding, as
indicated by a drastic decrease of binding affinity, even if only
one residue was substituted by alanine (Peuckert et al., 2009).
The two ligands [FeIII(Ent)]3 and [FeIII(mecam)]3 are bound in
an analogous way. The SIGMAA-weighted (FobsFcalc) electron-
density difference for these ligands is shown in Figures 3A
and 3B.
The relative position of the ligands in the binding pocket is
similar and the basic triad itself is well defined in both com-
plexes and differs only little in its position and distances com-
pared with the FeuA$[FeIII(BB)]3 complex (Figures 3C and 3D;
Table S1).
Themost obvious changesappear at residuesQ181andQ215.
In the FeuA$[FeIII(Ent)]3 complex, the side chain of Q181 is
rotated away from the binding pocket, resulting in an explicitly
weakened hydrogen bond. Q215 exhibits extended distances
to the ortho-oxygen atoms of the ligand, but forms an additional
hydrogen bond from its main chain amide N-H to the carbonyl
oxygen of one 2,3-DHB moiety. In the FeuA$[FeIII(mecam)]3
complex, no electron density for the side chain of Q181 was
observable, showing the loss of hydrogen bonds with the ligand.
Q215 shows additional hydrogen bonding from its main chain
amide N-H to the carbonyl oxygen of one 2,3-DHB moiety
(Figure 3D; Tables S1 and S2).
All other residues in the binding pocket show insignificant
changes and retain the overall shape and surface observed in
the FeuA$[FeIII(BB)]3 complex. A detailed list of all changes in
the binding pocket can be found in the Tables S1 and S2.
Stereoconfiguration and Structural Features
of the Ligands
Both complexes exhibit nearly C3 point symmetry and adopt
a L-configuration when bound by FeuA, which was already
observed spectroscopically in solution (Peuckert et al., 2009).
The ligands show trigonal twist angles of the three catecholate
groups relative to their almost C3 axes of 11.8
, 7.6, and 10.8
for [FeIII(Ent)]3 and 13.4, 11.3, and 12.3 for [FeIII(mecam)]3,
respectively. These twist angles generate an approximate octa-
hedral iron coordination. The torsion of the metal-chelating DHB
units of [FeIII(Ent)]3 and [FeIII(mecam)]3 is not as strong as
observed for [FeIII(BB)]3. It seems that the additional glycine
spacer in bacillibactin (between the metal center and the trilac-
tone moiety) generates further requirements concerning space,
sterical hindrance and torsion angles, resulting in a slightly
stronger tilting.907–919, July 29, 2011 ª2011 Elsevier Ltd All rights reserved 909
Figure 2. Overall Structures of FeuA-Siderophore Complexes
(A and B) The overall structures of (A) FeuA$[FeIII(Ent)]3 and (B) FeuA$[FeIII(mecam)]3. The N- and C-terminal domains and the connecting a helix of the protein
backbone are shown in different shades of blue and green, respectively. The ligand atoms are colored as follows:O red, N blue, Fe orange sphere, C yellow and
magenta, respectively.
(C) The N-terminal domains of apo- (gray) and holo-FeuA (red) were superpositioned. The distances between the conserved residues E90 and E221 are shown.
See also Figure S1.
(D) Superposition of FeuA complexed with [FeIII(BB)]3 (red), [FeIII(Ent)]3 (blue) and [FeIII(mecam)]3 (green). All Figures were created with PyMOL 1.3
(Schro¨dinger, 2010).
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Uptake of Fe-Enterobactin and Fe-mecam by FeuAWe also tested ferric complexes of the bacillibactin and enter-
obactin precursor 2,3-DHB and of the distantly related triscate-
cholate vibriobactin for absolute configurations at their metal
centers. Negative bands around 450 nm and positive ones
around 550 nm are indicative for iron-triscatecholate complexes
with L-configuration (Bluhm et al., 2002b). Whereas FeuA was
found to induce the formation of L-configured species in the
racemic mixture of FeIII(2,3-DHB)3, the configuration of the
[FeIII(VB)]3 complex remained unchanged (Figure 4). To deter-
mine the binding constants for the different ferric triscatecholate
ligands, fluorescence titration experiments were performed with
[FeIII(Ent)]3, [FeIII(mecam)]3, FeIII(2,3-DHB)3, and [Fe
III(VB)]3.
FeuA binds not only [FeIII(BB)]3 with high affinity (KD = 0.027 ±
0.001 mM) (Miethke and Skerra, 2010; Peuckert et al., 2009),
but also [FeIII(Ent)]3 (KD = 0.04 ± 0.01 mM). Our affinity constant
for [FeIII(Ent)]3 is in good agreement with previously published
data (Abergel et al., 2009; Miethke et al., 2006). The synthetic
siderophore [FeIII(mecam)]3 is bound with slightly lower affinity
(KD = 1.03 ± 0.03 mM), in contrast to the precursor Fe
III(2,3-
DHB)3, which shows significantly weaker binding (KD = 8.38 ±
0.26 mM) (Figure S4). For [FeIII(VB)]3, only unspecific binding
was observed. The low binding affinities for the two latter
complexes are supported by the missing stabilization of the
protein upon heat denaturation (Figure S2).
The crystal structure of the SBP CeuE from the food-
borne pathogen Campylobacter jejuni revealed a dimeric910 Chemistry & Biology 18, 907–919, July 29, 2011 ª2011 Elsevier L(CeuE)2${Fe
III(mecam)}2 complex. Two CeuE monomers were
bridged by a L,L-[{FeIII(mecam)}2]
6 binuclear complex
(Mu¨ller et al., 2006). Our structure, however, shows a single
[FeIII(mecam)]3 complex bound by one FeuA macromolecule
and is therefore clearly different from the (CeuE)2${Fe
III(mecam)}2
complex. The monomeric nature of the complex in solution was
also confirmed by size exclusion chromatography (data not
shown). Ferric mecam bound by FeuA mimics the coordination
mode and shape of a natural triscatecholate siderophore. The
aromatic moiety which substitutes the trilactone ring of the
natural siderophores enterobactin or bacillibactin is not recog-
nized by the protein and, furthermore, does not form p–p inter-
actions (for example, between two possibly head-to-head
symmetry-related molecules within a crystal).
Comparison of Binding Residues
The only other structurally characterized SBPs for catecholate-
type siderophores are the aforementioned CeuE from C. jejuni
(Mu¨ller et al., 2006) and FpiA (YclQ) from B. subtilis (Bugdahn
et al., 2010; Zawadzka et al., 2009), which binds the mixed cat-
echolate‒citrate siderophore petrobactin. The basic triad in
CeuE is composed of R117, R204, and R248. The binding
region of FpiA is lined with the basic residues K84, R104,
R192, H214, and R236, which were predicted to participate in
binding, based on comparison with the CeuE structure
(Zawadzka et al., 2009).td All rights reserved
Figure 3. Siderophore Binding Pocket of FeuA
(A and B) SIGMAA-weighted (FobsFcalc) electron-density difference is shown for [FeIII(Ent)]3 (yellow, contour level 2.7 s, calculated at 1.90 A˚ resolution) and
[FeIII(mecam)]3 (magenta, contour level 2.7 s, calculated at 2.15 A˚ resolution), respectively; 2FobsFcalc electron density (blue and green, respectively, contour
level 1 s) is shown for residues K84, K105, and R180 (C light blue and light green, respectively). For ligand coloring, refer to Figure 2. See also Figures S2 and S3.
(C) Overlay of the three different ligands in the binding pocket: [FeIII(BB)]3 (green), [FeIII(Ent)]3 (yellow), and [FeIII(mecam)]3 (magenta).
(D) Overlay of the residues of the first and second shell of the binding site for the triscatecholate ligands (C light red, light blue and light green for FeuA complexed
with [FeIII(BB)]3, [FeIII(Ent)]3, and [FeIII(mecam)]3, respectively). See also Tables S1 and S2.
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Uptake of Fe-Enterobactin and Fe-mecam by FeuAAn overlay of the structures of (CeuE)2${Fe
III(mecam)}2 and
FeuA$[FeIII(mecam)]3 shows clear differences in the positioning
of both the ligand and the basic triad (Figure 5). The
[{FeIII(mecam)}2]
6 dimer in CeuE is bound more shallow in the
binding pocket than [FeIII(mecam)]3 in FeuA. While R204 and
R248 in CeuE point upward from below the triscatecholate metal
center, the basic triad in FeuA appears more from the same level
or from above.
This tolerance in position of the crucial residues for sidero-
phore binding supports the substrate promiscuity of SBPs. It
seems that in addition to presence of the basic triad, the overall
shape of the binding site is of similar importance for selection of
a predefined substrate spectrum. Clarke et al. showed for the
ferric hydroxamate siderophore binding protein FhuD, that
even mutations in residues which only contribute to the overall
fold of the binding site may impair siderophore recognition
(Clarke et al., 2002b).
A multiple sequence alignment of known triscatecholate side-
rophore binding proteins is shown in Figure S6. Typical for class
III SBPs is the conserved fold, while the homology at the
sequence level is rather low (Table S3). The basic triad in the tris-
catecholate siderophore binding proteins FepB from E. coli,Chemistry & Biology 18,CeuE from C. jejuni, and VctP and ViuP from Vibrio cholerae is
not well conserved.
Mutational and Growth Studies
The sequence alignment in Figure S6 shows the two glutamate
residues E90 and E221 of FeuA, which are predicted to be
responsible for interaction with the transmembrane permease
FeuBC (interactionmodel, see Figure 6A). In contrast to the basic
triad, these two residues are well conserved for all six examined
proteins (the second glutamate residue in FpiA is substituted by
aspartate). To verify the physiological role of the two residues,
we performed mutational studies of the two residues in vivo. A
B. subtilis DfeuABC deletion mutant showed impaired growth
compared with the wild-type ATCC 21332. This mutant was
complemented with the native feuABC cluster or with a
feuAE90A,E221ABC double mutated gene cluster. While western
blot analysis confirmed a similar production of both FeuA vari-
ants, the feuAE90A,E221ABC complemented strain was not able
to grow under iron-limited conditions, whereas the strain com-
plemented with the native feuABC cluster showed stronger
growth compared with the wild-type (Figure 6B). This proves
the crucial role of E90 and E221 for the interaction with FeuBC907–919, July 29, 2011 ª2011 Elsevier Ltd All rights reserved 911
Figure 4. Stereoconfiguration of Ferric Triscatecholate Complexes
(A and B) Circular dichroism spectra of FeIII(2,3-DHB)3 and [Fe
III(VB)]3 in presence and absence of FeuA.
(C and D) Zoom on the [FeIII(Ent)]3 and [FeIII(mecam)]3 complexes in the FeuA binding pocket illustrating their L-configuration.
See also Figure S4.
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Uptake of Fe-Enterobactin and Fe-mecam by FeuAand for the transport process itself, according to the model in
Figure 6A. Fluorescence quenching analysis of the recombinant
protein variant FeuA-E90A,E221A proved that the binding affini-
ties for the ligands were in the same range as observed for the
wild-type protein.
Furthermore, the physiological availability of the examined
siderophores BB, Ent, and mecam to B. subtilis was tested by
growth analysis (Figure 6C). While supplementation with native
siderophores [FeIII(BB)]3 and [FeIII(Ent)]3 supported strongly
the growth of a B. subtilis DdhbC mutant, which is unable to
produceanycatecholatecompounds for iron acquisition (Miethke
et al., 2006), [FeIII(mecam)]3providedasignificantly lower growth
promotion. The iron-free siderophores apo-BB and apo-Ent were
also able to provide growth benefits to DdhbC, whereas the apo-
mecam feeded cultures showed significantly impaired growth
compared with the control experiments. The DdhbC DfeuABC
double mutant was drastically impaired in growth in presence of
all triscatecholate supplements, demonstrating the essential
and unique role of the FeuABC-YusV2 system for triscatecho-
late-dependent iron acquisition in B. subtilis (Figure 6C).
DISCUSSION
The ABC-type transporter FeuABC-YusV2 is responsible for tris-
catecholate siderophore import in Bacillus subtilis. We have912 Chemistry & Biology 18, 907–919, July 29, 2011 ª2011 Elsevier Lrecently shown that a basic triad composed of K84, K105, and
R180 is responsible for [FeIII(BB)]3 binding by FeuA, thereby
allowing solely a L-configuration at the triscatecholate-metal
center (Peuckert et al., 2009). In this work, we present cocrystal
structures of FeuA with ferric complexes of the best studied
siderophore enterobactin and the triscatecholate siderophore
analog mecam. This siderophore mimic is of special interest,
because it was reported to accumulate in the periplasm of
E. coli and to have a significantly lower iron delivery ratio
compared with Ent (Ecker et al., 1986; Matzanke et al., 1986),
probably also due to its nonhydrolyzable backbone. The
dimerization of the binding protein CeuE from C. jejuni by
a [{FeIII(mecam)}2]
6 dimer (Mu¨ller et al., 2006) also inspired
a new inhibition strategy for such binding proteins (Miethke
and Marahiel, 2007). Enterobactin on the other hand is a widely
distributed siderophore, produced by several Gram-negative
bacteria, such asEscherichia coli,Salmonella enterica,Klebsiella
spp., and Shigella spp. Therefore, understanding the detailed
capturing mode performed by a triscatecholate binding protein
for this siderophore is a crucial issue for exploring its overall
binding mechanism and furthermore, the interspecies competi-
tion for siderophores. Successful strategies require the develop-
ment of high-affinity transport systems with broad substrate
specificity. To establish cell surface receptors, which are able
to directly compete with the highly specific outer membranetd All rights reserved
Figure 5. Comparison of FeuA and CeuE Binding Pockets
(A and B) Binding residues in FeuA (green) and CeuE (yellow) with the ligands [FeIII(mecam)]3 and [{FeIII(mecam)}2]
6 (for ligand coloring, refer to Figure 2),
respectively.
(C and D) Electrostatic surface representation of the binding pockets (from 5 [red] to +5 [blue] kBT/ec), generated with APBS (Baker et al., 2001).
See also Figure S5.
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Uptake of Fe-Enterobactin and Fe-mecam by FeuAtransporters of Gram-negative bacteria, SBPs of Gram-positive
bacteria typically possess affinities toward their substrate in
a similar range.
The stabilization of FeuA by [FeIII(Ent)]3 and [FeIII(mecam)]3
against thermal denaturation is in a similar range compared
with the endogenous substrate [FeIII(BB)]3 and the overall struc-
tures of all three FeuA-ferrisiderophore complexes show no
significant changes among each other, contrary to the great
hinge motion between the apo- and holo structures. Large
domain movements are well known for b strand-bridged SBPs
of class I or II (e.g., 35 for the maltose binding protein; Sharff
et al., 1992) and have therefore been termed the ‘‘venus fly-
trap’’ mechanism. The connecting a helix between the two
domains in the ‘‘helical backbone’’ metal receptor superfamily
is assumed to induce rigidity into the structure, resulting in signif-
icantly smaller domain tilting upon ligand binding. Accordingly,
most examples of this superfamily show movements of only
a few degrees. The domain motion is thought to be important
for the specific recognition of SBPs by their cognate transmem-
brane permease.
The similar domain tilt in our three cocrystal structures empha-
sizes an important prerequisite for recognition of the conserved
residues E90 and E221 by the transmembrane permease
FeuBC. Our crystallographic analysis and furthermore theChemistry & Biology 18,molecular dynamics simulations of FhuD (Krewulak et al.,
2005) and BtuF (Kandt et al., 2006) as well as the recent struc-
tural characterization of the E. coli siderophore binding protein
FitE (Shi et al., 2009) suggest that at least some class III SBPs
are much more flexible than previously assumed. The recently
determined apo- and holo-crystal structures of the staphyloferrin
A and B binding proteins HtsA and SirA, respectively, from
Staphylococcus aureus showed a very small domain movement,
while the major conformational changes were accomplished by
three loops of the C-terminal domains (Grigg et al., 2010a,
2010b). The structure of BtuC2D2F reveals a much higher degree
of domain tilting in BtuF, than in the apo-/holo structures (Borths
et al., 2002; Hvorup et al., 2007; Karpowich et al., 2003). The
different behaviors of these structurally related proteins suggest
that the recognition of binding proteins by their cognate trans-
membrane permease is either different or much more compli-
cated than previously assumed.
The similar structural motion seen in all of our cocrystal struc-
tures, implying a similar recognition and transport mechanism is
provoked by the nearly identical binding mode of the related
siderophores. The basic triad, crucial for binding of the nega-
tively charged siderophore, differs slightly in its position. The
basic triad seems to be the common binding motif of triscate-
cholate siderophore binding proteins and was also observed in907–919, July 29, 2011 ª2011 Elsevier Ltd All rights reserved 913
Figure 6. FeuA-FeuBC Interaction Model, Mutational,
and Growth Studies
(A) Model for the interaction of the substrate binding protein
FeuA and the integral membrane permease FeuBC for ligand
translocation into the cytosol. Such interaction is proposed to
be mediated by the formation of salt bridges between the two
conserved glutamate residues E90 and E221 of FeuA and the
arginine residues R59 of FeuB and R53 of FeuC. This allows
FeuA to channel the bound ligand into the permease tunnel
and, through action of the ATP-hydrolyzing cassettes, to the
cytosolic side. FeuA is shown in orange; FeuB and FeuC are
shown in green. See also Figure S6 and Table S3.
(B) Growth analysis of B. subtilis strains. The final optical
density of the strains grown under iron-limited conditions in
absence () or presence (+) of 0.5% xylose is shown, the
standard deviations out of three independent replicates are
shown as error bars. B. subtilis strains ATCC 21332 (gray),
DfeuABC (red), DfeuABC + pXfeuABC (green) and B. subtilis
DfeuABC + pXfeuAE90A,E221ABC (yellow) were grown under
iron-limited conditions in absence () or presence (+) of 0.5%
xylose. A western blot using antibodies against FeuA and
confirming the expression of FeuA under the control of the
xylose promoter in absence () or presence (+) of 0.5% xylose
is shown above the corresponding bars. Multiple bands
observed in ATCC 21332 are most likely degradation products
of FeuA. See also Table S4.
(C) Growth analysis of B. subtilis DdhbC mutant (deficient in
both 2,3-DHB and BB biosynthesis) and B. subtilis DdhbC
DfeuABC double mutant (deficient in both catecholate side-
rophore biosynthesis and uptake). Cultures were grown in
Belitsky minimal medium (in triplicates at 37C for 12 h)
without addition of citrate and without or with different iron
source supplements. All indicated supplements were added
to a final concentration of 20 mmol L1 at the start of incuba-
tion. Standard deviations are shown as error bars.
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Uptake of Fe-Enterobactin and Fe-mecam by FeuAthe mammalian siderophore scavenger siderocalin, where
a basic triad coordinates the siderophores by hybrid electro-
static/cation-p interactions (Goetz et al., 2002). The FeuA
binding motif seems to perform solely electrostatic interactions
with the ligands, possibly due to the need for siderophore release
upon transport, which, in contrast, is prevented in the case of
siderocalin that shows much higher binding affinities (Abergel
et al., 2006; Goetz et al., 2002).
Recently, one more crystal structure of siderocalin (variant
K125A) became available in the Protein Data Bank (PDB code:
3CMP, resolution: 2.8 A˚) showing three siderocalin-K125Amole-
cules in the asymmetric unit. In two of them, the [FeIII(Ent)]3
complex was present in an undegraded form. Both are distorted
and show no high symmetry, neither at the triscatecholate metal
center, nor at the trilactone. The carbonyl groups of one mole-
cule point toward the metal center, whereas in the other
complex, they point sidewise away from the trilactone. Even
our crystal structure at much higher resolution than that of side-
rocalin-K125A$[FeIII(Ent)]3 showed a [FeIII(Ent)]3 complex with
a slightly distorted trilactone ring as well, but with the carbonyl
groups pointing away from the metal, thereby resembling the [VI-
V(Ent)]2 structure (with inverted stereoconfiguration). Calcula-
tions on the free [FeIII(Ent)]3 complex showed no significant en-
ergetical preferences for one of the two L-configured
conformations with the carbonyl groups either pointing toward
or away from the metal (Bluhm et al., 2002a). Therefore it seems
reasonable that [FeIII(Ent)]3 possesses a certain structural
diversity and can be bound in distinct conformations by different
binding proteins, which is attended by the sole recognition of the
catecholate moieties.
[FeIII(mecam)]3 forms one distinct conformation in complex
with FeuA. The monomeric protein-ligand complex which was
observed in solution (via size exclusion chromatography), was
also present in the crystal structure and differs clearly from the
[{FeIII(mecam)}2]
6 bridged CeuE dimer (Mu¨ller et al., 2006).
MM3 calculations indicated a mononuclear structure for the
ferric siderophore complex (Hay et al., 2001). The dimeric struc-
ture observed for CeuE based on ferric mecam dimerization
therefore either may be a crystallization artifact or is the ener-
getic consequence of binding to a differently shaped pocket.
The deep and sterically demanding binding cleft of FeuA
seems to be the reason for the permitted monomer formation,
as a [{FeIII(mecam)}2]
6 bridged FeuA dimer would result in steric
clashes of the two proteins (Figure S5).
This binding cleft may also be the reason for the inability
to bind the related triscatecholate siderophore complex
[FeIII(VB)]3. VB features two oxazoline moieties, which are
directly attached to two of its three catecholate subunits (Grif-
fiths et al., 1984; Keating et al., 2000). These oxazolines could
generate steric hindrance, which hence may prevent binding
by the narrow and tight binding pocket of FeuA. As themain frag-
ments which are recognized by the basic triad are the catecho-
late units, which are also present in VB, the reason of nonbinding
by FeuA has to be either the aforementioned steric hindrance or
perhaps the inability of [FeIII(VB)]3 to adopt a L-configuration.
A sequence alignment of FeuA, CeuE, and other known trisca-
techolate siderophore binding proteins displayed little homology
on the primary structure level. Most conserved residues are
typical for all siderophore binding proteins and have beenChemistry & Biology 18,described before (Clarke et al., 2002b). The basic triad is not
well conserved, as one could expect at least for the enterobactin
binding proteins CeuE and FepB. Furthermore, the overall folds
of the FeuA and CeuE binding pockets are quite distinct. The
binding pocket of CeuE contributes to its shallower binding of
the ligand, as shown in Figure 5. In this light, the evolution of ferric
siderophore binding pockets seem to have been independent in
different bacterial phyla, and might have been based on one
‘‘helical backbone’’ family ancestor that provided enough plas-
ticity to establish structurally diverse binding environments for
functionally similar recognition modes.
To our knowledge, the only siderophore binding protein which
has been structurally characterized with more than one ligand is
the ferric hydroxymate utilization protein FhuD from E. coli
(Clarke et al., 2000, 2002a). FhuD complexes with gallichrome,
coprogen, the drug desferal, and the siderophore-antibiotic
conjugate albomycin show similar cell dimensions and overall
structures, which we also observed for the FeuA complexes.
Likewise, the major coordination interfaces are located at the
iron-binding moieties. Contrary, the binding residues in FhuD
undergo significant conformational changes to accommodate
the structural features of each siderophore, whereas the basic
triad in FeuA shows no outstanding movement. This is presum-
ably due to the fact that the catecholatemoieties and their neigh-
boring amide bonds are identical for all three siderophores,
which may again explain discrimination of the structurally distant
[FeIII(VB)]3.
The rigid binding pocket, which is based on the L-mode
substrate specificity of FeuA leads to the nearly identical domain
movement of the protein, which, in turn, positions the two
conserved glutamate residues E90 and E221 conveniently to
interact with the basic residues of the transmembrane permease
FeuBC.Ourmutational studies underline the importance of these
two acidic residues for the transport process, which is consistent
with previous results on the vitamin B12, ferric citrate, and
hydroxamate siderophore transport systems of E. coli and
S. aureus, respectively, while the point mutations did not affect
binding of the ligands, which was also observed for the hydrox-
amate binding protein FhuD (Sebulsky et al., 2003).
The performed uptake studies affirmed the dominant role of
the endo- and exogenous triscatecholate siderophores BB and
Ent as high-affinity iron sources for B. subtilis, while the phy-
siological availability of (ferric) mecam has to be put into ques-
tion, although the crystallographic and in vitro data confirmed
its binding by FeuA. The lower growth promotion by
[FeIII(mecam)]3 is corresponding to the higher KD values ob-
tained in the fluorescence experiments in vitro. The import of
[FeIII(mecam)]3 should therefore be possible, but the accessi-
bility of the carried ferric ion in the cytosol could be impaired,
which is maybe caused by its nonhydrolyzable backbone. The
lower growth of B. subtilis DdhbC under supplementation with
apo-mecam could further be due to an inhibitory effect of this
chelator in a way that mecam is sequestering remaining traces
of iron in the medium, which does not become available to the
metabolism due to impaired [FeIII(mecam)]3 uptake and/or
cytosolic release.
Our experiments could not confirm a proposed secondary
uptake system for ferric Ent (Dertz et al., 2006), since deletion
of the feuABC transporter provided a drastic growth effect,907–919, July 29, 2011 ª2011 Elsevier Ltd All rights reserved 915
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Uptake of Fe-Enterobactin and Fe-mecam by FeuAeven if [FeIII(Ent)]3 was supplemented. Later experiments of the
group, which originally proposed this secondary transporter,
also failed to confirm its presence (Abergel et al., 2009). Never-
theless, a side effect for competitive ferric triscatecholate uptake
cannot be completely ruled out, since the characterization of the
petrobactin binding protein FpiA (YclQ) also provided some low-
affinity binding of [FeIII(Ent)]3 (Zawadzka et al., 2009).
In conclusion, the presented cocrystal structures provide
detailed insights into the capture of exogenous triscatecholate
siderophores by Bacillus subtilis and implied the importance of
the binding protein’s domain tilt and its exposed opposing gluta-
mates for subsequent transport processes, which has been
proved in vitro and in vivo. The deep binding cleft essentially
contributes both to high-affinity binding of the substrates, as
well as to limited recognition of related substrates possessing
unfavorable size or stereoconfiguration.
SIGNIFICANCE
Due to restricted bioavailability, the acquisition of iron is of
major importance for microbial survival and for virulence
of pathogens. One prominent iron-mobilizing strategy is
the secretion of high-affinity iron chelators, so-called side-
rophores. The inhibition of siderophore uptake systems by
artificial antagonists and channeling of siderophore-antibi-
otic conjugates as ‘‘Trojan Horse Antibiotics’’ are being
contemplated as novel antimicrobial tools. Therefore, a pre-
cise understanding of the molecular and structural recogni-
tion mode of both endo- and exogenous siderophores, as
well as synthetic analogs with antagonistic properties is
crucial for development of potentially new antibiotics. Sub-
strate binding proteins of Gram-positive bacteria typically
possess broader substrate specificities than outer mem-
brane receptors of Gram-negatives, while showing compa-
rable affinities. We investigated the triscatecholate binding
protein FeuA from the Gram-positive model organism
Bacillus subtilis in complex with an exogenous and a syn-
thetic siderophore. The complexes with ferric enterobactin
and ferric mecam revealed a similar structural behavior
compared with the complex with the endogenous sidero-
phore ferric bacillibactin (Peuckert et al., 2009). Both the
binding modes, the overall protein fold and domain move-
ments upon ligand binding were astonishingly conserved
throughout these complexes. The overall binding pocket of
FeuA is very rigid in size and shape and therefore limited in
its substrate tolerance, which is supported by the restriction
on L-stereoconfigured substrates. The similar domain tilt-
ing, representing the largest knownmovements within class
III binding proteins imply their significant importance for the
recognition by the transmembrane permease and the sub-
sequent transport process. The highly conserved residues
E90 and E221 have been proved to be crucial for this recog-
nition process between binding protein and membrane
permease. Another unique feature was the observation
of a monomeric form of the ferric mecam complex, which
is contrary to the dimer formation by CeuE from
Campylobacter jejuni, but nevertheless the biological avail-
ability of this synthetic iron chelator is impaired and leads to
inhibitory effects of growth during iron limitation.916 Chemistry & Biology 18, 907–919, July 29, 2011 ª2011 Elsevier LEXPERIMENTAL PROCEDURES
Preparation of Enterobactin, Vibriobactin, and Mecam
H6-Ent was obtained from the group of Christopher T. Walsh, Harvard Medical
School (Fischbach et al., 2005), H6-VB was purchased from EMC Micro-
collections (Tu¨bingen, Germany). H6-mecam was synthesized as described
elsewhere (Garrett et al., 1991; Tor et al., 1992). Loading with iron(III) was
done as described previously (Miethke et al., 2006).
Cloning, Overexpression, and Purification of Recombinant FeuA
and FeuA-E90A,E221A
For expression of FeuA, plasmid pOK01 (Miethke et al., 2006) was used. For
cloning of feuA-E90A,E221A, pOK01 was used as template and the first point
mutation was introduced using Phusion High-Fidelity DNA Polymerase
(Finnzymes) and the primers feuAE90Afor and feuAE90Arev. After sequencing,
the second point mutation was introduced using the primers feuAE221Afor
and feuAE221Arev. Sequencing confirmed the correct introduction of both
point mutations.
Overexpression of recombinant FeuA and its variant FeuA-E90A,E221A and
purification of protein-siderophore complexes was done as described previ-
ously (Peuckert et al., 2009).
Crystallization and Data Collection
Crystals of the FeuA$[FeIII(Ent)]3 complex were grown at 18C by sitting drop
vapor diffusion from 600 nl drops. The drops were composed of 300 nl of the
crystallization solution (0.1 mol L1 phosphate-citrate [pH 5.2], 34% (v/v) PEG
600) and 300 nl FeuA$[FeIII(Ent)]3 at a concentration of 40mgml1. Crystals of
FeuA$[FeIII(mecam)]3 grew under similar conditions using 0.1 mol L1 phos-
phate-citrate (pH 5.0), 45% (v/v) PEG 300 as crystallization solution. Crystals
of diffraction quality grew between 2 days and 2 weeks. For cryocrystallo-
graphic analysis the crystals were taken out of the solution and directly flash
frozen using liquid nitrogen. All chemicals used for crystallization were of the
highest commercially available purity.
Cocrystals with [FeIII(Ent)]3 and [FeIII(mecam)]3 belong both to space
group P1211, as do the cocrystals with [Fe
III(BB)]3 (PDB code: 2WHY) (Peuck-
ert et al., 2009). Diffraction data sets were collected at a temperature of 100 K
at beamline ID14-2 at the European Synchrotron Radiation Facility (ESRF),
Grenoble, France and data reduction was performed with the programs XDS
and XSCALE (Kabsch, 2010a, 2010b).
Structure Determination and Refinement
Due to the significantly altered cell parameters, a Phaser search (McCoy et al.,
2007) was carried out before refinement, using the FeuA$[FeIII(BB)]3 structure
(PDB code: 2WHY) asmodel. TLS and restrained refinement of both structures
was performed using REFMAC5 (CCP4, 1994; Murshudov et al., 1997) and
COOT (Emsley et al., 2010). At the end of the refinement Rwork/Rfree values
for FeuA$[FeIII(Ent)]3 converged to 18.5% and 24.3%, respectively and for
FeuA$[FeIII(mecam)]3 to 17.8% and 23.7%, respectively. Ligand parameters
were calculated using the PRODRG server (Schu¨ttelkopf and van Aalten, 2004)
using starting coordinates taken from the Lipocalin 83$[GaIII(Ent)]3 structure
for [FeIII(Ent)]3 and from the Hetero-compound Information Centre Uppsala
(HIC-Up) (Kleywegt and Jones, 1998) for [FeIII(mecam)]3, respectively. Super-
position of the structures and calculation of root mean square deviations was
done using the SSM algorithm implemented in COOT.
Circular Dichroism Spectroscopy
CD spectroscopywas carried out in 0.5 cmpath length cuvettes, using a J-810
Spectropolarimeter (JASCO) and a protein concentration of FeuA or the
complexes with [FeIII(Ent)]3, [FeIII(mecam)]3, [FeIII(VB)]3, or FeIII(2,3-DHB)3
of 2.5 mmol L1 in a buffer containing solely 5 mmol L1 Na-phosphate pH
7.0 for denaturation curves. The measuring range was from 5C to 95C using
a temperature slope of 1C min1 and a data pitch of 0.2C. The monitored
wavelength was 222 nm with a bandwidth of 1 nm, a response of 1 s and
with standard sensitivity. The measuring conditions for reverse curves were
the same; the sample was kept at 95C for 1 min and then allowed to cool
down using the aforementioned temperature slope.
The circular dichroism spectra of FeIII(2,3-DHB)3 and [Fe
III(VB)]3 with and
without FeuA were recorded at 22.5C (constant temperature), with atd All rights reserved
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0.2 nm, a response of 1 s and with standard sensitivity. The scanning speed
was 50 nm min1 and the presented data are an average of 10 scanning
circles. The concentrations of the ferric complexes and the protein were
830 mmol L1 in buffered water (5 mmol L1 Na-phosphate [pH 7.0]).
Fluorescence Spectroscopy
For intrinsic fluorescence spectroscopy a FP-6500 spectrofluorometer
(JASCO) was used. Experiments were carried out at 20C (constant tempera-
ture), using an excitation and emission bandwidth of 5 nm each, a response of
0.5 s and low sensitivity. For each measurement series, a protein solution of
5 mmol L1 in 20mmol L1 Tris-HCl (pH 7.5) was placed in a 13 1 cm2 cuvette,
and titrated stepwise with concentrated ligand stock solution. After stirring for
3 min and further 2 min resting, fluorescence was measured by sample exci-
tation at 280 nm and emission monitoring from 300 to 500 nmwith a data pitch
of 0.5 nm. Emission maxima obtained at 330 nm were used for plotting and
binding constant calculation. Therefore, data were set to 100% starting fluo-
rescence intensity and fitted by nonlinear regression analysis (KaleidaGraph
3.52, Synergy Software) using the equation
F =
½Pt½LtKD fP2 + ½Lt½PtKD fL2 + ½Pt + ½Lt +KD fPL2
+ ðfP + fL  fPLÞ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ½Pt + ½Lt +KD2
4
 ½Pt½Lt
s
;
according to the Law of Mass Action in a one-site binding model, where [P]t
and [L]t are total protein and ligand concentrations, respectively, fP, fL, and
fPL are the relative molar fluorescence coefficients of the free protein, the
free ligand, and the protein-ligand complex, respectively, and KD is the disso-
ciation constant. KD and fPL were set as free parameters, and fP was set to
100% mM1 according to the starting value.
Mutational and Growth Experiments
Strains and General Methods
Bacterial strains, plasmids, and primers used are listed in Table S4. Antibiotics
used for selection ofBacillus subtilis strains were used in the following concen-
trations: chloramphenicol (5 mg ml1), kanamycin (10 mg ml1). Antibiotics for
selection of plasmid containing TOP10 or XL1Blue strains were used at the
following concentrations: ampicillin (100 mg ml1), kanamycin (50 mg ml1).
Purified FeuA was used for the generation of polyclonal antibodies in rabbits.
For this, 500 mg of protein was send to the company (Pineda, Berlin) for immu-
nization. After 110 days of immunization, sera were obtained.
Cloning of feuABC in pX Plasmid and Bacillus subtilis
Transformation
The region containing the genes feuABCwith its cognate ribosomal binding site
was amplified from Bacillus subtilis ATCC 21332 chromosomal DNA, intro-
ducing BamHI (underlined) in the flanking regions. This fragment was cloned
into the pCR4Blunt-TOPO vector yielding plasmid pTATCC-feuABC. Plasmid
pTATCC-feuABC was digested with BamHI and the fragment containing the
feuABC geneswas ligated into the pX vector (Kim et al., 1996), yielding plasmid
pXfeuABC. E90A and E221A variants of FeuA were generated using the
plasmid pXfeuABC, Phusion DNA polymerase and the primers feuAE90Afor,
feuAE90Arev, feuAE221Afor, and feuAE221Arev (modified codons are marked
bold and underlined), generating the plasmids pXfeuAE90ABC and
pXfeuAE221ABC, respectively. A double E90A-E221A FeuA variant was gener-
ated from pXfeuAE221ABC using the primers feuAE90Afor and feuAE90Arev,
yielding the plasmid pXfeuAE90A,E221ABC. The correct sequences of plasmids
and the insertion of mutants were confirmed by sequencing (GATC Biotech).
Plasmids pXfeuABC and pXfeuAE90A,E221ABC were linearized with KpnI and
used to transform B. subtilis BMM110 (DfeuABC) (Miethke et al., 2006). Trans-
formants were selected in antibiotic-containing LB plates. Chromosomal DNA
of the transformants was isolated and the integration of feuABC and
feuAE90A,E221ABC at the amyE locus of B. subtilis DfeuABC was confirmed
by PCR.
In Vivo Analysis of the FeuA-E90A,E221A Variant
Bacillus subtilis strains were grown under agitation (250 rpm) at 37C. For
growth under iron depletion, Belitzky minimal medium (0.5% fructose) without
citrate and without iron was used. For feuABC expression, cultures ofChemistry & Biology 18,B. subtilis at OD600 = 0.05 were induced with 0.5% xylose. After 12 hr of
growth, the optical density was measured. To detect if the FeuA-E90A,E221A
variant was correctly expressed, B. subtilis strains were grown in LB at 37C
for 12 hr. Cells were harvested by centrifugation at 13,000 rpm and disrupted
by sonication. Twenty-five micrograms of total protein extract was loaded on
a 12% SDS-polyacrylamide gel. FeuA was detected using antibodies raised
against purified FeuA protein.
Growth Experiments
The strains B. subtilis BMM100 (DdhbC) and B. subtilis BMM111 (DdhbC
DfeuABC) (Miethke et al., 2006) were inoculated in Belitsky minimal medium
(Stu¨lke et al., 1993) with 0.5% (w/v) glucose as carbon source and without
addition of citrate and iron salt and were grown over night to induce iron limi-
tation. Iron-starved cultures were then inoculated to a starting OD600 of 0.03 in
fresh minimal medium without or with different iron source supplements (all
added to 20 mmol L1 final concentration). For each condition, triplicates
were prepared and grown in volume scales of 1 ml in round-bottom PE tubes
at 37C and 250 rpm for 12 hr. Optical cell density was monitored spectropho-
tometrically, and averages of final growth were plotted together with the cor-
responding standard deviations.
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